Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Statistical Methods in Medical Research|January 8, 2014
Summary measure of discrimination in survival models based on cumulative/dynamic time-dependent ROC curvesJérôme Lambert, Sylvie Chevret
Hematological Oncology|April 8, 2022
Comparing apples and oranges: The ZUMA-7, TRANSFORM and BELINDA trialsCôme Bommier, Jérôme Lambert, Catherine Thieblemont
Contemporary Clinical Trials|April 15, 2025
Evaluation of the survival-inferred fragility index to assess the robustness of the estimated treatment effect on survival endpointsRoxane Couturier, Sylvie Chevret, Jérôme Lambert
Statistical Methods in Medical Research|October 17, 2012
A minimal net reclassification improvement to assess predictions of intensive care mortalityYacine Tandjaoui Lambiotte Redondo, Jérôme Lambert, Sylvie Chevret
Hemasphere|February 10, 2022
What Prognostic Markers Should Be Evaluated in Marginal Zone Lymphoma? A Survey Among Leading International ExpertsCôme Bommier, Jérôme Lambert, Grzegorz Nowakowski, et al.
Hematological Oncology|March 17, 2022
Finding a consensus on time-to-event endpoints definitions in marginal zone lymphoma: A Delphi methodCôme Bommier, Jérôme Lambert, Grzegorz Nowakowski, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|June 6, 2024
Immunomodulatory effects of single and combined exposure to ZnO and TiO2 nanoparticles on rainbow trout challenged with Aeromonas salmonicida achromogenesMahaut Beghin, Jérôme Lambert, Joachim Sturve, et al.
Journal of Clinical Epidemiology|September 17, 2023
A methodological review of population-adjusted indirect comparisons reveals inconsistent reporting and suggests publication biasArnaud Serret-Larmande, Belkacem Zenati, Agnès Dechartres, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2025
Improving the Reporting of Trials Evaluating Organ-Support Therapies Using Multistate ModelingDavid Hajage, Stéphane Gaudry, Alain Combes, et al.
Leukemia & Lymphoma|February 24, 2022
Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trialsCôme Bommier, Mathilde Ruggiu, Aymeric Monégier, et al.
Pageof 9